01 / DESIGN
What was studied?
Human adipose-derived stromal cells were studied in culture and after pretreatment before use in a mouse kidney-injury model.
02 / FINDINGS
What did the researchers report?
MOTS-c activated metabolic signaling but reduced proliferation and increased selected senescence markers. Pretreated cells did not restore the expected repair outcomes.
03 / LIMITS
How should it be interpreted?
This negative, context-dependent finding cautions against equating pathway activation with benefit. Human-derived cells are not the same as a clinical intervention in human patients.
Loti Labs Peptide editorial reading note. Based on the linked source record. Methods and corrections.